<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231825</url>
  </required_header>
  <id_info>
    <org_study_id>18-26268-1</org_study_id>
    <nct_id>NCT04231825</nct_id>
  </id_info>
  <brief_title>At-home Transcranial Alternating Current Stimulation During Multitasking</brief_title>
  <official_title>At-home Transcranial Alternating Current Stimulation During Multitasking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal is to replicate in-lab results from transcranial alternating current stimulation
      (tACS) with at-home tACS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be assessed in-lab on multitasking and sustained attention abilities.
      Participants will be sent home with a tACS device to be used at-home for five days while
      engaged in a multitasking paradigm that is different from the multitasking outcome measure
      used pre/post tACS. After the at-home stimulation is complete, participants return to UCSF
      for a final in-lab assessment of multitasking and sustained attention ability.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuroracer Performance Change From Baseline</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Assessment of multitasking ability using change from baseline scores in d' cost (metric of discriminability)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test of Visual Attention (TOVA)</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Assessment of sustained attention ability using response time and response time variability change from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Multitasking Behavior</condition>
  <arm_group>
    <arm_group_label>Verum Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 6-Hz tACS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frequency Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive 1-Hz tACS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial alternating current stimulation</intervention_name>
    <description>Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
    <arm_group_label>Frequency Control</arm_group_label>
    <arm_group_label>Verum Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  Grade 12 or more education

          -  Normal or corrected to normal vision and hearing

          -  Ability to complete cognitive tasks

          -  Ability to cooperate and comply with all study procedures

          -  Ability to tolerate tACS

        Exclusion Criteria:

          -  Neurological or psychiatric disorders

          -  Family history of epilepsy

          -  History of seizures

          -  Prior head trauma

          -  Pregnant

          -  Implanted electronic devices (e.g., pacemaker)

          -  IQ &lt; 80

          -  Taking psychotropic medication

          -  Taking anti-depressants or anti-anxiety medication

          -  Substance abuse

          -  Color blind

          -  Glaucoma

          -  Macular degeneration

          -  Amblyopia

          -  Strabismus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Zanto, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sandler Neurosciences Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 8, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The dataset includes self-reported information, behavioral and electrophysiological data. The final dataset will be stripped of identifiers prior to release for sharing, thereby anonymizing the data. We will make the anonymized data available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to attempt to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. This will be in accordance with human subject regulations.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The data will be available after the results have been determined and the study researchers are unblinded. The data will be available indefinitely upon request.</ipd_time_frame>
    <ipd_access_criteria>Contact PI.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 3, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT04231825/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

